David Fagan Email & Phone Number

United States

Greater Minneapolis-St. Paul Area

National lead for Field Reimbursement Team.

Greater Minneapolis-St. Paul Area

Leading a field team responsible for providing important reimbursement information to healthcare professionals and maximizing patient access.

Greater Minneapolis-St. Paul Area, (Managed Western United States)

Directed and led a team of eight Field Reimbursement Managers (FRMs) responsible for a multi-billion dollar Multiple Sclerosis (MS) franchise portfolio. The team covered the largest MS neurology accounts in 29 states in the Western US. Worked in an extensive cross-functional matrix with sales, account management, brand marketing, managed care marketing, and patient services to support all field-based reimbursement and market access activity, ensuring barrier-free access to a four product MS and two product hemophilia portfolio.

National In Scope

Developed and implemented strategies to secure appropriate Medicare product access for neurology product portfolio with large commercial plans and Medicare Administrative Contractors (MACs). Established Medicare strategy for top tier Part D health plans including UnitedHealthcare (UHC), Cigna, and Aetna. Created Medicare reimbursement strategy for both current and pipeline products. Served as liaison between Managed Markets Team and Biogen Idec Government Strategy Office.

National In Scope

Designed and implemented field-based educational and promotional reimbursement tools in support of operational brand plan goal of barrier-free access to two product MS therapy portfolio. Managed relationships with outside reimbursement vendors, creating programs and tools to accomplish product access goals. Established collaborative relationships with brand marketing, Product Review Committee (PRC), patient services, legal, regulatory, and internal Managed Markets and Reimbursement (MMR) teams. Led cross-functional scenario planning on various healthcare reform provisions impacting pharmaceutical manufacturers. Contributed to assessing the financial impact of healthcare reform, including the Medicare Part D Coverage Gap Discount Program

National In Scope

Worked collaboratively with the Biogen Idec Government Strategy Team to influence national and local Centers for Medicare & Medicaid Services (CMS) policy and access for marketed oncology and neurology product portfolios, as well as Medicare reimbursement strategy development for pipeline products. Performed Medicare policy/legislative analysis, including the Medicare Modernization Act (MMA) and the Affordable Care Act (ACA), and translated impact on product portfolio to brand team and senior leadership. Represented Biogen Idec on various working groups within the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA). Worked collaboratively with the Council on Radionuclides and Radiopharmaceuticals (CORAR) trade organization. Developed Medicare Part B and Part D strategies in alignment with brand team goals

Greater Minneapolis-St. Paul And Surrounding Area

Managed field access and reimbursement in key oncology/hematology and neurology accounts to ensure barrier-free access to product portfolio. Collaborated cross-functionally to address Medicare, Medicaid, and private payer coverage/reimbursement issues related to promoted oncology (Zevalin and Rituxan) and neurology (Tysabri and Avonex) drugs.

Greater Minneapolis-St. Paul And Surrounding Area

Maintained access to oncology product portfolio at large regional and national payers, and collaborated with the field sales team to provide reimbursement support for high-volume oncology/hematology offices. Developed and managed contractual agreements and pull-through programs with large national/regional managed care organizations and pharmacy benefit managers such as United (UHC), BCBS, and Prime Therapeutics.

Greater Minneapolis-St. Paul And Surrounding Area

Forged strategic alliances and partnerships with the largest oncology GPO customers to ensure appropriate uptake of product portfolio and drive sales. Developed and managed contractual agreements with strategic oncology practice networks including US Oncology, ION, Oncology Associates, state oncology societies, and oncology specialty wholesalers.

Greater Minneapolis-St. Paul And Surrounding Area

Developed relationships with key oncology decision-makers in several influential academic accounts driving sales of oncology drug portfolio.